369 related articles for article (PubMed ID: 22393049)
1. Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays.
Phuan PW; Ratelade J; Rossi A; Tradtrantip L; Verkman AS
J Biol Chem; 2012 Apr; 287(17):13829-39. PubMed ID: 22393049
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica IgG does not alter aquaporin-4 water permeability, plasma membrane M1/M23 isoform content, or supramolecular assembly.
Rossi A; Ratelade J; Papadopoulos MC; Bennett JL; Verkman AS
Glia; 2012 Dec; 60(12):2027-39. PubMed ID: 22987455
[TBL] [Abstract][Full Text] [Related]
3. Membrane assembly of aquaporin-4 autoantibodies regulates classical complement activation in neuromyelitis optica.
Soltys J; Liu Y; Ritchie A; Wemlinger S; Schaller K; Schumann H; Owens GP; Bennett JL
J Clin Invest; 2019 Apr; 129(5):2000-2013. PubMed ID: 30958797
[TBL] [Abstract][Full Text] [Related]
4. Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4 M1/M23 isoforms and orthogonal arrays.
Crane JM; Lam C; Rossi A; Gupta T; Bennett JL; Verkman AS
J Biol Chem; 2011 May; 286(18):16516-24. PubMed ID: 21454592
[TBL] [Abstract][Full Text] [Related]
5. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
Nicchia GP; Mastrototaro M; Rossi A; Pisani F; Tortorella C; Ruggieri M; Lia A; Trojano M; Frigeri A; Svelto M
Glia; 2009 Oct; 57(13):1363-73. PubMed ID: 19229993
[TBL] [Abstract][Full Text] [Related]
6. Optic neuritis in neuromyelitis optica.
Levin MH; Bennett JL; Verkman AS
Prog Retin Eye Res; 2013 Sep; 36():159-71. PubMed ID: 23545439
[TBL] [Abstract][Full Text] [Related]
7. Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica.
Ratelade J; Smith AJ; Verkman AS
Exp Neurol; 2014 May; 255():145-53. PubMed ID: 24636863
[TBL] [Abstract][Full Text] [Related]
8. Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Rossi A; Moritz TJ; Ratelade J; Verkman AS
J Cell Sci; 2012 Sep; 125(Pt 18):4405-12. PubMed ID: 22718347
[TBL] [Abstract][Full Text] [Related]
9. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Phuan PW; Zhang H; Asavapanumas N; Leviten M; Rosenthal A; Tradtrantip L; Verkman AS
Acta Neuropathol; 2013 Jun; 125(6):829-40. PubMed ID: 23677375
[TBL] [Abstract][Full Text] [Related]
10. Isotetrandrine Reduces Astrocyte Cytotoxicity in Neuromyelitis Optica by Blocking the Binding of NMO-IgG to Aquaporin 4.
Sun M; Wang J; Zhou Y; Wang Z; Jiang Y; Li M
Neuroimmunomodulation; 2016; 23(2):98-108. PubMed ID: 27064690
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase.
Tradtrantip L; Asavapanumas N; Verkman AS
Mol Pharmacol; 2013 Jun; 83(6):1268-75. PubMed ID: 23571414
[TBL] [Abstract][Full Text] [Related]
12. Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica.
Ratelade J; Asavapanumas N; Ritchie AM; Wemlinger S; Bennett JL; Verkman AS
Acta Neuropathol; 2013 Nov; 126(5):699-709. PubMed ID: 23995423
[TBL] [Abstract][Full Text] [Related]
13. Model of aquaporin-4 supramolecular assembly in orthogonal arrays based on heterotetrameric association of M1-M23 isoforms.
Jin BJ; Rossi A; Verkman AS
Biophys J; 2011 Jun; 100(12):2936-45. PubMed ID: 21689527
[TBL] [Abstract][Full Text] [Related]
14. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.
Tradtrantip L; Zhang H; Saadoun S; Phuan PW; Lam C; Papadopoulos MC; Bennett JL; Verkman AS
Ann Neurol; 2012 Mar; 71(3):314-22. PubMed ID: 22271321
[TBL] [Abstract][Full Text] [Related]
15. Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity.
Duan T; Smith AJ; Verkman AS
Acta Neuropathol Commun; 2019 Jul; 7(1):112. PubMed ID: 31296268
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: A Target of Autoimmunity in the Central Nervous System.
Abe Y; Yasui M
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454180
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4 by the Small Molecule Blocker Melanthioidine.
Xu H; Gong Y; Jiao Y; Guo J; Zhao L; Yang J; Tong H; Sun M; Li M
Curr Pharm Des; 2023; 29(10):793-802. PubMed ID: 36998134
[TBL] [Abstract][Full Text] [Related]
18. AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding.
Palazzo C; Buccoliero C; Mola MG; Abbrescia P; Nicchia GP; Trojano M; Frigeri A
Acta Neuropathol Commun; 2019 Apr; 7(1):51. PubMed ID: 30935410
[TBL] [Abstract][Full Text] [Related]
19. Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
Tradtrantip L; Felix CM; Spirig R; Morelli AB; Verkman AS
Neuropharmacology; 2018 May; 133():345-353. PubMed ID: 29428821
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Iorio R; Fryer JP; Hinson SR; Fallier-Becker P; Wolburg H; Pittock SJ; Lennon VA
J Autoimmun; 2013 Feb; 40():21-7. PubMed ID: 22906356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]